543 related articles for article (PubMed ID: 25218176)
21. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
[TBL] [Abstract][Full Text] [Related]
22. Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.
Nguyen CQ; Sharma A; She JX; McIndoe RA; Peck AB
Exp Eye Res; 2009 Mar; 88(3):398-409. PubMed ID: 19103199
[TBL] [Abstract][Full Text] [Related]
23. A novel lacrimal gland autoantigen in the NOD mouse model of Sjögren's syndrome.
Esch TR; Poveromo JD; Aikins MC; Levanos VA
Scand J Immunol; 2002 Mar; 55(3):304-10. PubMed ID: 11940237
[TBL] [Abstract][Full Text] [Related]
24. Endoplasmic reticulum stress causes autophagy and apoptosis leading to cellular redistribution of the autoantigens Ro/Sjögren's syndrome-related antigen A (SSA) and La/SSB in salivary gland epithelial cells.
Katsiougiannis S; Tenta R; Skopouli FN
Clin Exp Immunol; 2015 Aug; 181(2):244-52. PubMed ID: 25845745
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory effect of peroxisome proliferator-activated receptor-γ (PPAR-γ) on non-obese diabetic mice with Sjogren's syndrome.
Li X; Xu B; Wang Y; Wei L
Int J Clin Exp Pathol; 2014; 7(8):4886-94. PubMed ID: 25197359
[TBL] [Abstract][Full Text] [Related]
26. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
Haneji N; Hamano H; Yanagi K; Hayashi Y
J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
[TBL] [Abstract][Full Text] [Related]
27. Androgen influence on lacrimal gland apoptosis, necrosis, and lymphocytic infiltration.
Azzarolo AM; Wood RL; Mircheff AK; Richters A; Olsen E; Berkowitz M; Bachmann M; Huang ZM; Zolfagari R; Warren DW
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):592-602. PubMed ID: 10067962
[TBL] [Abstract][Full Text] [Related]
28. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
29. Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis.
Lisi S; Sisto M; Lofrumento DD; Cucci L; Frassanito MA; Mitolo V; D'Amore M
J Autoimmun; 2010 Sep; 35(2):160-70. PubMed ID: 20673622
[TBL] [Abstract][Full Text] [Related]
30. Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB.
Lisi S; Sisto M; Lofrumento DD; D'Amore M
Lab Invest; 2012 Apr; 92(4):615-24. PubMed ID: 22157716
[TBL] [Abstract][Full Text] [Related]
31. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome.
Schrader AM; Camden JM; Weisman GA
Arch Oral Biol; 2005 Jun; 50(6):533-40. PubMed ID: 15848146
[TBL] [Abstract][Full Text] [Related]
32. A novel NOD-derived murine model of primary Sjögren's syndrome.
Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.
Zhou J; Jin JO; Patel ES; Yu Q
Cytokine; 2015 Dec; 76(2):244-252. PubMed ID: 26255211
[TBL] [Abstract][Full Text] [Related]
34. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome.
Saito I; Terauchi K; Shimuta M; Nishiimura S; Yoshino K; Takeuchi T; Tsubota K; Miyasaka N
J Clin Lab Anal; 1993; 7(3):180-7. PubMed ID: 8509947
[TBL] [Abstract][Full Text] [Related]
35. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
36. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
[TBL] [Abstract][Full Text] [Related]
37. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
38. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
[TBL] [Abstract][Full Text] [Related]
39. Immunogenetics of primary Sjögren's syndrome in Colombians.
Anaya JM; Mantilla RD; Correa PA
Semin Arthritis Rheum; 2005 Apr; 34(5):735-43. PubMed ID: 15846589
[TBL] [Abstract][Full Text] [Related]
40. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
